ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies
Duke Picks Lyerly To Direct Cancer Center
Parkinson Heads Oncology At Amgen
NCI Says Men Should Eat 9 Fruits/Vegetables A Day, Begins Campaign Targeting Black Men
16 Institutions Win NCI Awards for Phase I Trials
EPIC, PLCO Studies Show High Fiber Diet Cuts Cancer Risk
Funding Opportunities. (8-page issue).
Includes April issue of Business & Regulatory Report (8 pages).
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
- FDA’s OCE publishes three final guidances to increase clinical trial enrollment
